Prednisone can increase the amount of time stomach acid sits in contact with the lining of your esophagus, even at moderate doses taken for just a week or two. In a controlled study of asthma patients, a short course of oral prednisone roughly doubled measurable acid exposure in the lower esophagus compared to placebo. The link between prednisone and acid reflux is well-documented, and managing it usually involves a combination of timing strategies, over-the-counter medications, and, when possible, choosing lower-impact corticosteroid alternatives.
What pH Monitoring Studies Actually Found
The clearest direct evidence comes from a study that used 24-hour esophageal pH monitoring to measure acid exposure in patients with stable asthma. During a prednisone phase, the total percentage of time that acid was present in the lower esophagus jumped from about 2.5% on placebo to roughly 6% on prednisone. Acid exposure in the upper esophagus also increased, from about 0.3% to 0.8%. Both differences were statistically significant.1PubMed. Oral corticosteroids increase esophageal acid contact times in patients with stable asthma
Those numbers may sound small in absolute terms, but the relative change matters. In the lower esophagus, acid contact time more than doubled. In the upper esophagus, it nearly tripled. Over days or weeks of prednisone therapy, that extra acid exposure adds up and can produce the burning, chest discomfort, and sour taste that people associate with reflux.
How Prednisone Promotes Reflux Without Increasing Stomach Acid
Here is where the story gets interesting, and where the common assumption falls apart. You might expect that prednisone makes reflux worse by ramping up acid production in the stomach. The pH monitoring study tested for exactly that and found no significant change in basal or stimulated gastric acid secretion during the prednisone phase.1PubMed. Oral corticosteroids increase esophageal acid contact times in patients with stable asthma The stomach was not making more acid. The study also found no measurable changes in lower esophageal sphincter pressure on manometric testing. So the valve at the top of the stomach was not obviously weaker, either.
This leaves a few plausible explanations. Corticosteroids are known to affect smooth muscle tone throughout the gastrointestinal tract, and they can promote transient relaxations of the lower esophageal sphincter, the brief openings that allow acid to splash upward. These relaxations might not show up as a change in resting sphincter pressure on a standard manometry test, but they can still increase the number of reflux episodes over 24 hours. Prednisone also suppresses prostaglandin production, much like NSAIDs do, which can weaken the protective mucus layer in both the stomach and esophagus. With less mucosal protection, even a normal amount of acid can do more damage and feel more irritating.
There is also evidence that corticosteroids can slow gastric emptying, meaning food and acid linger in the stomach longer than usual. A fuller stomach puts more upward pressure on the esophageal sphincter, increasing the likelihood of reflux events. The combined effect of these subtle changes adds up to meaningfully more acid bathing the esophagus, even though no single mechanism dramatically changes on its own.
Why You May Not Notice Symptoms Right Away
One of the more surprising findings from the pH monitoring research was that patients did not report a significant increase in reflux symptoms during the prednisone phase, despite the measurable jump in acid exposure.1PubMed. Oral corticosteroids increase esophageal acid contact times in patients with stable asthma This disconnect between objective acid exposure and subjective symptoms is actually common in reflux research more broadly, but it has a specific twist with prednisone.
Corticosteroids are potent anti-inflammatory drugs. Part of their job is to dial down the body’s inflammatory response, including in tissues like the esophageal lining. So while prednisone is increasing acid contact with the esophagus on one hand, it may simultaneously be suppressing the inflammation and pain signaling that would normally alert you to the damage on the other. The result is that you can accumulate esophageal acid injury without the warning signs you would normally feel.
This matters in a practical sense. If you are on a course of prednisone and feel fine, that does not necessarily mean your esophagus is fine. People who already have a tendency toward reflux, or who take prednisone repeatedly or for extended periods, can develop esophageal irritation that only becomes symptomatic after the prednisone course ends and the anti-inflammatory masking effect wears off. Treating reflux proactively during a prednisone course, rather than waiting for symptoms to appear, is a reasonable approach for this reason.
Dose, Duration, and Who Faces the Most Risk
Not everyone who takes a five-day burst of prednisone for a sinus infection will develop meaningful reflux. Several factors determine how much your esophagus is affected.
- Dose: Higher daily doses of prednisone produce more pronounced GI effects. Standard burst doses for asthma or allergic reactions (40 to 60 mg per day) carry more reflux risk than low-dose maintenance therapy (5 to 10 mg per day), though even lower doses can increase acid exposure over time.
- Duration: A three-day taper is very different from a months-long course. The longer you take prednisone, the more cumulative acid exposure builds up. Patients on chronic corticosteroid therapy for conditions like rheumatoid arthritis or inflammatory bowel disease face a substantially higher risk of GI complications than those on short bursts.
- Pre-existing reflux: If you already have gastroesophageal reflux disease, prednisone can push a manageable baseline into a more symptomatic range. People with a hiatal hernia or a history of esophagitis are more vulnerable.
- Concurrent medications: Taking prednisone alongside NSAIDs like ibuprofen or naproxen significantly increases the risk of upper GI irritation, because both drug classes suppress prostaglandin-mediated mucosal defense through different pathways.
- Body position and timing: Taking prednisone at night, or lying down shortly after taking it, gives acid more opportunity to contact the esophagus because gravity is no longer helping keep stomach contents down.
Age also plays a role. Older adults tend to have weaker sphincter tone and slower esophageal clearance to begin with, so the additional burden from prednisone is more likely to tip them into symptomatic territory.
Practical Ways to Manage Reflux While Taking Prednisone
If you need prednisone and are concerned about reflux, or already experiencing it, several strategies can reduce your acid exposure.
Taking prednisone with food, ideally a meal rather than just a snack, is the simplest starting point. Food buffers stomach acid and reduces direct irritation of the stomach and esophageal lining. Morning dosing is preferable to evening dosing for reflux purposes, because you are upright for most of the hours that follow. Avoid lying down for at least two to three hours after taking your dose.
Elevating the head of your bed by about six inches (using a wedge pillow or blocks under the bedframe, not just stacking pillows) helps prevent nighttime reflux, which is when the longest acid contact episodes tend to occur. Reducing or avoiding alcohol, caffeine, chocolate, and large fatty meals during a prednisone course may also help, since all of these independently promote sphincter relaxation.
These lifestyle changes alone are often enough for people on short courses. For longer courses or higher doses, you will likely need medication support.
Taking Antacids With Each Dose
An older but well-designed study tested the strategy of taking an antacid alongside each divided dose of prednisone or prednisolone. The antacid combination (aluminum hydroxide gel and magnesium trisilicate) was taken with every steroid dose, and this approach proved highly effective at reducing both the frequency and severity of digestive symptoms during corticosteroid therapy.2PubMed Central. Effectiveness of antacids in reducing digestive disturbances in patients treated with prednisone and prednisolone
The key detail is the timing. Antacids work locally and briefly, neutralizing acid that is present in the stomach right now. Taking one once a day while dosing prednisone three times a day leaves most of the day unprotected. The study’s approach of pairing an antacid with each steroid dose makes pharmacological sense because it puts the buffer in place exactly when the drug is passing through the upper GI tract.
Modern over-the-counter antacids (calcium carbonate products like Tums, or aluminum-magnesium combinations like Maalox) work similarly. They are inexpensive, widely available, and generally safe for short to moderate courses. The main downsides are that they only last one to two hours per dose and can interfere with the absorption of certain other medications if taken at the same time, so spacing them about two hours from other drugs is a good practice.
When You Need Stronger Acid Suppression
For people on longer prednisone courses, higher doses, or those with pre-existing reflux disease, antacids alone may not be enough. Two classes of prescription and over-the-counter medications provide more sustained acid suppression.
H2 receptor blockers (famotidine is the most commonly used) reduce acid production for roughly 8 to 12 hours per dose. They are a reasonable middle ground: stronger and longer-lasting than antacids, with a good safety profile for short-to-medium-term use. Taking famotidine 20 to 40 mg once or twice daily can meaningfully reduce reflux symptoms during a prednisone course.
Proton pump inhibitors (omeprazole, lansoprazole, esomeprazole, and others) are the most potent acid suppressors available. They shut down acid production at the source and are the standard treatment for erosive esophagitis and moderate-to-severe GERD. If you are on chronic prednisone and have documented reflux or esophageal irritation, a PPI is likely appropriate. PPIs take a day or two to reach full effect, so starting one at the beginning of a prednisone course rather than waiting for symptoms to escalate makes the most practical sense.
One thing to be aware of: there has been growing attention to the risks of long-term PPI use, including concerns about bone density, magnesium levels, and kidney function. For a one- or two-week prednisone burst, these concerns are essentially irrelevant. For people on chronic corticosteroid therapy who also end up on a chronic PPI, the bone density question is worth discussing with a doctor, since prednisone itself also affects bone health.
Corticosteroid Alternatives With Fewer GI Side Effects
Not every inflammatory condition requires systemic prednisone. Where the treatment target allows it, corticosteroids that act locally rather than throughout the entire body tend to produce fewer side effects, including less GI impact.
Budesonide is the best-studied example. In a randomized trial comparing budesonide to prednisolone for active Crohn’s disease, corticosteroid-related side effects were significantly less common with budesonide.3New England Journal of Medicine. A comparison of budesonide with prednisolone for active Crohn’s disease Budesonide is designed to act primarily in the gut (for intestinal conditions) or in the airways (for asthma, as an inhaled formulation) and undergoes extensive first-pass metabolism in the liver, so much less of the drug reaches the systemic circulation. This means fewer of the whole-body effects that prednisone is notorious for, reflux included.
For asthma specifically, inhaled corticosteroids (fluticasone, budesonide, beclomethasone) are the maintenance backbone and carry minimal systemic GI risk. The relationship between prednisone and reflux is most relevant during flare-ups that require oral steroids, or in patients with conditions like lupus, polymyalgia rheumatica, or transplant rejection where systemic corticosteroids cannot easily be replaced.
If your doctor has prescribed prednisone and you are experiencing significant reflux, it is worth asking whether a locally-acting corticosteroid could work for your specific condition. The answer is sometimes no, but when a local option exists, the GI tradeoff is substantially better.
Distinguishing Reflux From Direct Pill Irritation
There is a related but distinct problem that can mimic reflux symptoms during prednisone therapy: direct irritation of the esophageal lining by the tablet itself. This is sometimes called pill esophagitis, and it happens when a pill dissolves against the esophageal wall instead of reaching the stomach. The result is a localized chemical burn that feels like severe heartburn or chest pain, typically in the mid-chest area.
Pill esophagitis is more common with certain drugs (doxycycline, potassium supplements, and bisphosphonates are frequent culprits), but any large or caustic tablet can cause it if swallowed without enough water or followed by lying down. Prednisone tablets are not the worst offenders, but taking them dry or with a tiny sip of water does create risk, especially for people with any esophageal narrowing or motility problems.
The practical distinction matters because pill esophagitis is managed differently from reflux. Acid-suppressing drugs help with reflux but do nothing to prevent a pill from sticking to the esophageal wall. The fix for pill esophagitis is mechanical: swallow the tablet with a full glass of water, stay upright for at least 30 minutes, and avoid taking pills right before bed. These overlap with good reflux hygiene, so they are worth adopting during any prednisone course regardless.
What Happens After You Stop Prednisone
Most people find that reflux symptoms improve within days to a couple of weeks after finishing a prednisone course, as the drug clears the system and the esophagus begins to heal. Prednisone has a biological half-life of roughly 18 to 36 hours, and its effects on GI motility and mucosal defenses fade over a similar timescale once you stop taking it.
There are two scenarios where reflux may linger. First, if prednisone unmasked or worsened an underlying reflux tendency that was previously subclinical, stopping the steroid removes one contributing factor but does not fix the baseline anatomy or sphincter dysfunction. Some people discover they have GERD only because a prednisone course made it symptomatic for the first time. If reflux persists for more than two to three weeks after completing prednisone, it is worth pursuing as a standalone issue rather than assuming it will resolve on its own.
Second, people who have been on long-term prednisone and taper off may experience a rebound increase in inflammation throughout the body, including in the esophageal and gastric mucosa. This rebound can temporarily worsen reflux symptoms before things settle. Continuing acid-suppressing medication for a few weeks after the taper finishes, rather than stopping everything at once, can smooth out this transition.
If you were started on a PPI specifically because of prednisone-related reflux, talk to your prescriber about when to step down. The usual approach is to switch from a PPI to an H2 blocker for a week or two, then stop entirely, rather than discontinuing the PPI abruptly, which can cause its own acid rebound effect.